Filing Details
- Accession Number:
- 0001240679-17-000035
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-06 17:34:01
- Reporting Period:
- 2017-09-01
- Accepted Time:
- 2017-09-06 16:34:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
806517 | Psychemedics Corp | PMD | Services-Medical Laboratories (8071) | 581701987 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1250730 | I Michael Schaffer | C/O Psychemedics Corporation 125 Nagog Park Acton MA 01720 | Vp Of Laboratory Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.005 Par Value | Disposition | 2017-09-01 | 981 | $21.16 | 41,273 | No | 4 | S | Direct | |
Common Stock, $.005 Par Value | Disposition | 2017-09-05 | 4,400 | $20.37 | 36,873 | No | 4 | S | Direct | |
Common Stock, $.005 Par Value | Disposition | 2017-09-06 | 2,167 | $20.14 | 34,706 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.00 to $21.22, inclusive. The reporting person undertakes to provide to Psychemedics Corp., any security holder of Psychemedics Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.26 to $20.54, inclusive. The reporting person undertakes to provide to Psychemedics Corp., any security holder of Psychemedics Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- Includes an additional 188 shares acquired since May 23, 2017 under the Company's Dividend Reinvestment Plan.